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a b s t r a c t
The Mood and Anxiety Symptoms Questionnaire (MASQ) was developed to measure the symptom-
dimensions of the tripartite model of anxiety and depression. A 30-item short adaptation of the MASQ
(MASQ-D30) was previously developed and validated in adult psychiatric outpatients. The aim of the
present study was to evaluate the validity and reliability of the MASQ-D30 in a sample of adolescents and
young adults. Help-seeking adolescents from Australia (N¼147; mean age: 17.7 years; 58.8% female)
completed the original, 90-item MASQ. Conﬁrmatory Factor Analysis (CFA) was used to evaluate the
construct validity (a 3-factor structure) of the original MASQ and the MASQ-D30. Internal consistencies
and correlations with other instruments were calculated and compared between versions. CFA showed
that the intended 3-factor structure ﬁt adequately to the MASQ-D30 data (CFI¼0.95; RMSEA¼0.08).
Internal consistencies ranged from 0.85 to 0.92 across the scales and patterns of correlations with the
Center for Epidemiological Studies-Depression (CES-D) indicated adequate convergent/divergent proper-
ties. Importantly, the observed psychometric characteristics were comparable with the original MASQ
and alternative short-forms. Results indicated that the MASQ-D30 is a valid and reliable instrument in
young people, allowing for quick assessment of the tripartite dimensions of depression and anxiety.
& 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Depression and anxiety have traditionally been treated as two
separate clinical categories, discernible from a healthy state. This
view has been challenged for several reasons. First, the high
comorbidity of depression and anxiety implies common clinical
and etiological factors, which suggest that their separation in
diagnostic systems such as the DSM and ICD is unjustiﬁed [e.g.
(Mineka et al., 1998)]. Second, the distribution of depressive and
anxiety symptoms in the general population is not dichotomous,
but continuously distributed, with many individuals lying between
the healthy and severely pathological ends of the continuum
(Kendell, 1989; Kendell and Jablensky, 2003). Third, the use of a
syndrome-approach leads to heterogeneous disease-categories,
which are unhelpful for treatment or our understanding of
underlying etiology [e.g. (Clark and Watson, 1991; Widiger and
Samuel, 2005].
Dimensional approaches to psychopathology are an alternative.
These assume that symptomatology can be described by patterns
of distinct dimensional scores, with each dimension used to rate
the severity of a speciﬁc symptom-domain along the full con-
tinuum from healthy to pathological (Goldberg, 2000). One
advantage of these dimensions is that they are symptom-speciﬁc
and circumvent the problem of comorbidity. In addition, they are
more representative of the natural distribution of psychopathol-
ogy in the general population and offer more statistical power in
research (MacCallum et al., 2002; Altman and Royston, 2006).
Models describing the structure of co-existing dimensions have
been popular in depression and anxiety research (Shankman and
Klein, 2003). Of these, the ‘tripartite model’ (Clark and Watson,
1991) is one of the most extensively studied. This model assumes
that symptomatology of depression and anxiety can be described
with three dimensions. ‘General Distress’ encompasses general
symptoms of psychological distress, which are evident in both
depression and anxiety and account for their high comorbidity.
‘Anhedonic Depression’ describes the lack of positive affect and
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loss of energy, a speciﬁc feature of depression. ‘Anxious Arousal’
describes the symptoms of somatic hyperarousal, a speciﬁc feature
of anxiety, especially of panic disorder. The model and its structure
has been validated in a number of populations (Chorpita et al.,
2000; Joiner and Lonigan, 2000; Keogh and Reidy, 2000; De Beurs
et al., 2007).
The Mood and Anxiety Symptoms Questionnaire (MASQ) was
introduced to measure the tripartite dimensions (Watson et al.,
1995a, 1995b). The MASQ has been shown to have adequate
psychometric properties (Reidy and Keogh, 1997; Keogh and
Reidy, 2000; De Beurs et al., 2007), although some studies have
found that MASQ data does not represent a pure 3-factor structure
(Burns and Eidelson, 1998; Boschen and Oei, 2006; Buckby et al.,
2008). This is likely due to redundant items, which are correlated
with more than one or none of the tripartite dimensions (Bedford,
1997; Keogh and Reidy, 2000; De Beurs, et al., 2007). This, together
with the fact that the lengthy 90-item questionnaire may be
unsuitable for administration in large studies, suggested the need
for a shorter version of the measure. The 30-item adaptation of the
MASQ (the MASQ-D30) was developed by selection of the 10 best
ﬁtting items for each of the three dimensions (for more details on
the construction of the MASQ-D30, see Wardenaar et al., 2010).
Psychometric analyses have shown adequate internal consistency,
convergent validity and construct validity of the MASQ-D30 scales
in both clinical and healthy samples (Wardenaar et al., 2010).
Although other short forms of the MASQ have been developed
(Casillas and Clark, 2000; Osman et al., 2011), we have chosen here
to focus primarily on the validation of the MASQ-D30 because
these scales have been externally validated with biological factors,
such as metabolic factors (Luppino et al., 2011), cortisol levels
(Wardenaar, et al., 2011), sets of Single Nucleotide Polymorphisms
(van Veen et al., 2012) and clinical factors, such as long term
outcome of psychopathology (Wardenaar et al., 2012).
Previous research has shown that the tripartite dimensions can
be effectively used to describe the variations in affect and
hyperarousal in younger populations (Chorpita, et al., 2000;
Daleiden et al., 2000; Joiner and Lonigan, 2000; Laurent and
Ettelson, 2001; De Bolle et al., 2010). Different scales have been
used to do this, often combining scales and/or items from different
inventories. Such approaches being rather cumbersome and with
the full MASQ being too long and containing many redundant
items, a short form such as the MASQ-D30 could be especially
suitable to measure the tripartite dimensions in younger popula-
tions. To date, no short-form of the MASQ has been validated in
adolescent or young adult patient samples. This is unfortunately
given the potential of a MASQ short form to limit the burden of
questionnaire administration to patients. Therefore, the current
study was aimed to evaluate whether the MASQ-D30 short form
would be useful and psychometrically feasible in our target
population. Analyses of validity and reliability of responses to
the MASQ-D30 were conducted, using data collected with original
90-item MASQ data in a young help-seeking sample (n¼147;
age¼15–24 years). Construct validity was evaluated with Con-
ﬁrmatory Factor Analyses (CFA), correlations with other scales
were assessed to evaluate convergent/divergent validity, discrimi-
native ability was evaluated by comparison of mean GD, AD and
AA scores between different diagnostic groups, and internal
consistency was evaluated with different methods. To better
understand the potential usefulness of the MASQ-D30 in this
sample, we directly compared the MASQ-D30 and MASQ-90 scale
characteristics to evaluate the trade-off between shortening the
scale and psychometric quality. Finally, to prevent an overly
exclusive focus on the MASQ-D30, supplementary analyses were
conducted with all other short-forms of the MASQ, enabling a full
and thorough evaluation of the feasibility of a MASQ short form in
our target population
2. Method
2.1. Participants and procedure
Orygen Youth Health (OYH) is a public mental health program for young people
between 15 and 24 years old in north and west metropolitan Melbourne, Australia.
The service provided at OYH has three components: Early Psychosis Prevention and
Intervention Center (EPPIC; Edwards et al., 2002), which is a service for people with
ﬁrst-episode psychotic disorder, Personal Assessment and Crisis Evaluation (PACE);
Yung et al., 2007), which targets individuals at ultra-high risk for psychosis, and
Youthscope, a service for individuals with non-psychotic disorders.
The current sample comprised individuals who were referred, but not neces-
sarily accepted, into Youthspace. Assessment was conducted as close as possible to
the time of referral. A full description of the psychiatric diagnoses of this cohort,
assessed with the Structured Clinical Interview for DSM-IV (SCID; (First et al., 1997),
is described by Godfrey et al. (2005). Brieﬂy, 69 participants met criteria for a
current mood disorder, 61 for a current anxiety disorder, 31 for current substance
use disorder, 23 for conduct or oppositional deﬁance disorders, and 18 met criteria
for other non-psychotic disorders. There was substantial comorbidity.
Exclusion criteria were: known organic cause for presentation, known intel-
lectual disability (IQo70), and inability to speak English. The study was approved
by Melbourne Health Human Research and Ethics Committee. Of the total included
patients, 151 (74.0% of patients invited to participate) completed one or more
questionnaires. Of these, 147 subjects (97.4%) provided MASQ data during the
research period. The sample consisted of 86 females (58.5%) and the mean age was
17.7 years (S.D.¼2.6). The sample consisted of 115 adolescents (age 20–24 years)
and 35 young adults (age 15–19). The CES-D (administered at the same time as the
MASQ) was available for 131 of the included subjects (89.1%).
2.2. Instruments
The original 90-item MASQ was administered to participants (Watson et al.
1995a, 1995b). This self-report measure is used to assess anxiety and depression
symptoms on a 5-point scale (1¼not at all, 5¼extremely). The MASQ-D30 scales
and analyses were based on the assessed 90-item version. The Center for
Epidemiologic Studies Depression Scale (CES-D) (20 self-report items) was used
to assess depressive symptomatology in the past week (Radloff, 1977). This
measure rates frequency of symptoms on a four-point scale. We computed the
subscales for the CES-D as presented by Radloff (1991) for adolescents and young
adults: ‘Depressive affect’, ‘Lack of happiness’, ‘Somatic & Rumination’, ‘Interperso-
nal’. All compound (sub)scales were used as continuous severity indicators.
2.3. Analyses
Analyses were conducted with IBM SPSS (version 20.0), Mplus version 5.0
(Muthén and Muthén, 1998–2008) and EQS (Bentler, 2006). CFA’s were used to
investigate the ﬁt of the hypothesized a three-factor model to the collected MASQ
item responses. For CFA, Weighted least squares (WLSMV) and polychoric correla-
tion matrices were used for model-estimation because model indicators were
categorical. Several ﬁt indices were used to evaluate model ﬁt. For good model ﬁt,
chi-square (χ2) should be low; Root Mean Square Error of Approximation (RMSEA)
should be close to zero and the Comparative Fit Index (CFI) higher than 0.90 or 0.95
for respectively acceptable or good model ﬁt (Brown, 2006). Fit was compared
between the hypothesized 3-factor model and alternative models (1-factor). In
addition, our data enabled comparison of model-ﬁt factor (co)variances and item-
loadings between the MASQ-D30 and the original MASQ. In addition to the CFA
models, the WLSMV estimated models were parameterized as item response
theory (IRT) models and the information function curves were plotted for each
scale to gain some insight in the scale reliability as a function of underlying
severity.
To evaluate the psychometric properties of the MASQ-D30, several statistical
analyses were performed. Cronbach0s α coefﬁcient was used to evaluate the
internal consistency for each subscale of the MASQ-D30. Because α automatically
increases with scale length, we used the Spearman-Brown formula (see (1)) to
estimate the hypothetical α’s for the short-form scales if they had the same length
as the original MASQ-scales (Nunnally and Bernstein, 1994).
To enable calculation of accurate average inter-item-correlations and corre-
sponding 95% conﬁdence intervals (95% CI), a Fisher’s Z-transformation was applied
ﬁrst to the correlation matrix to correct for the skewed distribution of correlation
coefﬁcients (Fisher, 1921). Back-transformed mean correlations (r) and 95% CI’s are
reported. In addition to α and inter-item correlations, the Greatest Lower Bound
(GLB) reliability was computed with EQS. The GLB represents the lower bound of
the range within which the true reliability (ρ) of a scale lies (GLBoρo1). Using a
factor model framework, computation of the GLB separates measurement error
from the actual common item variance, yielding a reliability estimate that is much
less prone to underestimate internal consistency than coefﬁcient α (Sijtsma, 2009).
To investigate the convergence with other measurements (convergent validity),
Spearman’s correlations (ρ) were computed between the MASQ-D30 subscales and
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the CES-D subscales. The discriminative ability of the speciﬁc MASQ-D30 scales was
assessed by comparison of mean scale-scores between different diagnosis groups.
For completeness, we repeated analyses on the two other MASQ short-forms,
namely the Mini-MASQ (Casillas and Clark, 2000) and the Anxiety Depression
Distress Inventory-27 (ADDI-27; Osman et al., 2011), to compare the usefulness of
the tools. These analyses are presented as supplementary data.
αlong ¼
Nαshort
1þðN1Þαshort
ð1Þ
αlong represents the estimated α if item-number was increased; αshort represents
the Cronbach’s α of the short-form scale; N represents the scale-elongation factor
(e.g. N¼2 if item-number is doubled).
3. Results
3.1. Conﬁrmatory factor analyses
Results of the CFA are shown in Table 1. In comparison to a
1-factor model, the hypothesized 3-factor model showed adequate
ﬁt (CFI¼0.95; RMSEA¼0.08) to the data. In this factor-model, all
items loaded signiﬁcantly (po0.05) onto their respective factors
and factor (co)variances were signiﬁcant. The factor correlations
were moderate-high (r¼0.50–0.77). A 3-factor bifactor-model
showed even better ﬁt, suggesting existence of one overall severity
factor (potentially explaining the substantial correlations, reported
above) and 3 subscale-speciﬁc factors. This indicates that the
underlying structure of the MASQ-D30 data is best described by
a combination of general and speciﬁc constructs.
We also ﬁtted a 3-factor model to the full MASQ-data to enable
comparison between the short and original forms (see Table 1).
Here again, a bifactor model (CFI¼0.93; RMSEA¼0.09) showed
better ﬁt than a regular 3-factor model. Although these results
have limited precision due to our relatively small n, they point
towards comparable underlying structures for the short- and
original forms.
3.2. Item response theory characteristics
The WLSMV-based 3-factor model was re-parameterized as an
IRT model and the information functions were provided for each of
the three separate scales (see Fig. 1). The information curves
showed that each of the scales provided most information around
the means of their respective IRT scores (θ) and were of compar-
able width. When compared more speciﬁcally between scales, GD
was slightly more informative below its mean level and GD above
its mean level. These results indicate that the MASQ-D30 scales
provide good information at the mean levels of severity in our
target population.
3.3. Internal consistency and reliability
Cronbach’s α coefﬁcients for the MASQ-D30 and original MASQ
are shown on the diagonals of Table 2. For the MASQ-D30, alphas
ranged from 0.85 to 0.91 and GLB’s ranged from 0.91 to 0.96. The
mean inter-item correlation was 0.53 (95%CI: 0.34–0.64) for GD,
0.56 (95%CI: 0.43–0.66) for AD, and 0.37 (95%CI: 0.22–0.50) for AA.
The mean inter-item correlations were signiﬁcantly larger than the
often used cutoff of 0.3 for AD and GD. For AA, the meanwas larger
than 0.3, but the cutoff lay within the 95% CI.
For the original MASQ, coefﬁcients were slightly higher: alphas
ranged from 0.91 to 0.95 and GLB’s ranged from 0.96 to 0.98,
which was likely because of the longer scale lengths. The equiv-
alency of internal consistency across the MASQ-D30 and the full-
length scale was supported by subsequent calculations using the
Spearman-Brown formula. If the MASQ-D30 scales would be
extended to the length of their original MASQ counterparts, alphas
would be 0.95 for GD, 0.97 for AD and 0.91 for AA, which are very
similar to the full scale alpha’s. The average inter-item correlations
for the original MASQ were 0.52 (95%CI: 0.39–0.63) for GD, 0.47
(95%CI: 0.32–0.60) for AD, and 0.38 (95%CI: 0.23–0.52) for AA.
Here again, only GD and AD had mean inter-item correlations that
were signiﬁcantly larger than 0.3 and the cut-off lay within the
95% CI for AA.
Taken together the similar patterns of alpha’s and inter-item
correlations indicated that the internal consistencies of the MASQ-
D30 scales were adequate and comparable to those of the
original MASQ.
3.4. Scale intercorrelations
The intercorrelations (Spearman’s ρ) for the MASQ-D30 and the
original MASQ are presented in Table 2. In line with the tripartite
Table 1
Conﬁrmatory factor analyses.
Model χ2 d.f. CFI RMSEA
MASQ-D30 1-factor 383.7 55 0.72 0.20
3-factor 127.7 64 0.95 0.08
bifactora 116.6 66 0.96 0.07
Original MASQ 3-factorb 193.5 83 0.92 0.10
bifactorc 184.9 82 0.93 0.09
All results based on WLSMV estimation and polychoric correlation matrices.
CFI¼Comparative Fit Index; RMSEA¼Root Mean Square Error of Approximation.
a Each item loading on its speciﬁc scale factor and an overall severity factor.
b The 3-factor model was constructed analog to the tripartite model as
presented by de Beurs et al. (2007).
c Each item loading on its speciﬁc scale factor (following de Beurs et al. (2007))
and an overall severity factor.
Fig. 1. Information function curves for each of the MASQ-D30 scales as a function
of θ S.D.’s.
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model, the general scale of GD showed moderately strong correla-
tions with both AD (ρ¼0.54) and AA (ρ¼0.66), whereas the
speciﬁc AD and AA scales were moderately correlated (ρ¼0.36).
The 95% CI’s of the correlations between AA and GD and between
AA and AD did not overlap, indicating signiﬁcantly different
interrelatedness. The pattern of correlations was similar to that
for the original MASQ, which indicates that the discrimination
between the scales was largely unaffected by the scale-shortening
process.
3.5. Correlations with the CES-D
The correlations of the MASQ-D30 and original MASQ scales
with the CES-D subscales are presented in Table 3. GD was most
strongly correlated with the CES-D subscale ‘depressed affect’
(ρ¼0.75) and moderately correlated with all other CES-D sub-
scales. In line with its speciﬁc anhedonic nature, AD was correlated
highest with ‘lack of happiness’ (ρ¼0.72). AD showed lower
correlations with ‘somatic & retardation’ (ρ¼0.53) and ‘interper-
sonal problems’ (ρ¼0.39), which are outside the AD measurement
domain. As expected, AA was correlated highest with ‘somatic &
retardation’ (ρ¼0.70). AA was correlated lower with ‘lack of
happiness’ (ρ¼0.47), consistent with its speciﬁcally somatic nat-
ure and distinctness from depression-speciﬁc AD. The patterns of
correlations of the original MASQ with the CES-D subscales were
largely similar, indicating that both scales have similar convergent
and divergent properties.
3.6. Discriminative ability
The mean MASQ-D30 scale-scores for different diagnostic
groups are shown in Table 4. Patients with any mood disorder
(including all kinds of comorbidity; n¼59) had higher scores on all
scales than patients without mood disorders (all other diagnoses;
n¼74). Patients with any anxiety disorder (including all kinds of
comorbidity; n¼53) had a signiﬁcantly higher mean GD score
than those without an anxiety disorder (all other diagnoses;
n¼80). In addition, the mean AA scale score was higher, but this
difference was marginally signiﬁcant (p¼0.07). Anxiety and non-
anxiety patients showed no difference on the AD scale. This
pattern of difference was similar to the pattern that was found
for the full-length scales. Taken together, these analyses give some
preliminary evidence for the discriminative ability of the MASQ-
D30 scales among different patient groups. The GD scale is
increased in both mood and anxiety disorder groups; the AD scale
is only increased in those with mood-disorders. The AA-scale was
increased in mood and anxiety-disorders and failed to discrimi-
nate anxiety- from non-anxiety patients.
4. Discussion
The aim of the current study was to evaluate the validity and
reliability of the MASQ-D30 in a sample of help-seeking young
people. This was done by comparing the MASQ-D30 factor
structure with that of the original MASQ. We also investigated
associations between MASQ-D30 and original MASQ subscales and
those of the CES-D. Using CFA, it was shown that the MASQ-D30
scales represent an underlying 3-dimensional structure. Internal
consistencies were satisfactory and comparable to the original
MASQ. MASQ-D30 subscales showed divergent and convergent
correlations with the various subscales of the CES-D.
Preliminary tests of the ability of the MASQ-D30 scales to
discriminate between mood and anxiety showed partly satisfac-
tory results with GD being increased in both disorders and AD only
in mood-disorders, which is in line with tripartite model expecta-
tions. The AA scale, however, did not show the anxiety-speciﬁc
increases that would be expected based on the model. On the one
hand, results could reﬂect the fact that our sample was mostly
comprised of severe patients with several co-occurring disorders
(e.g. mood, substance and conduct disorders), making any differ-
entiation between them on the basis of a speciﬁc (AA) scale very
difﬁcult. On the other hand, the results may reﬂect the issue that
the AA-scale is mostly speciﬁc to panic disorder and not to anxiety
disorders as a whole (Mineka et al. 1998). Despite this, the
majority of the presented results support the psychometric quality
of the MASQ-D30 in the target population.
Given that the 90-item MASQ is lengthy and time consuming to
complete, the MASQ-D30 is a viable alternative. It is short and
easier to complete, which in research equates to lower costs and
Table 2
Spearman correlations and Cronbach’s α coefﬁcients for the scales of the MASQ-D30 and the original MASQ (n¼147).
Version Scales General distress Anhedonic depression Anxious arousal
MASQ-D30 General distress 0.91 [0.94] – –
Anhedonic depression 0.54 (0.38–0.66) 0.92 [0.96] –
Anxious arousal 0.66 (0.55–0.75) 0.36 (0.19–0.52) 0.85 [0.91]
Original MASQ General distress 0.95 [0.98] – –
Anhedonic depression 0.62 (0.49–0.73) 0.95 [0.98] –
Anxious arousal 0.71 (0.60–0.79) 0.39 (0.20–0.54) 0.91 [0.96]
All correlations are given with 95% conﬁdence intervals between parentheses, estimated through 1000 bootstrap draws. Underlined numbers on the diagonal are Cronbach’s
α coefﬁcients greatest Lower Bound reliability coefﬁcients are displayed between brackets. MASQ¼Mood and Anxiety Symptoms Questionnaire; MASQ-D30¼30-item
adaptation of the MASQ.
Table 3
Spearman correlations between the scales of the MASQ-D30/original MASQ and the
CES-D subscales (n¼131).
Version Scales CES-D scales
Depressed
affect
Happiness Somatic &
retardation
Inter-
personal
MASQ-
D30
General
distress
0.75 0.65 0.71 0.61
Anhedonic
depression
0.57 0.72 0.53 0.39
Anxious
arousal
0.63 0.47 0.70 0.41
Original
MASQ
General
distress
0.81 0.66 0.73 0.62
Anhedonic
depression
0.59 0.74 0.56 0.44
Anxious
arousal
0.64 0.44 0.70 0.41
All correlations pairwise and with po0.01. MASQ¼Mood and Anxiety Symptoms
Questionnaire; MASQ-D30¼30-item adaptation of the MASQ; CES-D¼Center for
Epidemiologic Studies Depression Scale.
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participant burden. Moreover, the MASQ-D30 overcomes the
problem of weak or complex factor loadings of the original MASQ,
which makes it a stronger operationalization of the tripartite
model (Wardenaar et al., 2010).
The hypothesized 3-factor model showed adequate ﬁt to
MASQ-D30 data. Fit indices were comparable to those of the
original MASQ. This ﬁnding is similar to that of Wardenaar et al.
(2010). They demonstrated that the MASQ-D30 ﬁt was similar to
that of the original MASQ in large samples of adults with depres-
sion (mean ages 38–42 years). It has previously been shown that
the tripartite model can be effectively applied to adolescent and
young adult populations (Chorpita et al., 2000; Daleiden et al.,
2000; Joiner and Lonigan, 2000; Laurent and Ettelson, 2001; De
Bolle, et al., 2010). The current ﬁndings suggest that the MASQ-
D30 provides a good index of these three dimensions of psycho-
pathology in young people, and that it should be considered as a
very useful assessment tool in this population.
Other support for the validity of the MASQ-D30 in young
people comes from its satisfactory internal consistency, showing
that item responses within the same subscale are highly corre-
lated. This was further supported by the average inter-item
correlations. Although internal consistencies of the MASQ-D30
were slightly lower than the original MASQ in this sample,
adjusting them for equivalency of the length of the two measures
suggested that internal consistencies of the MASQ-D30 and
original MASQ were comparable. In addition, when only common
variance was considered in the calculation of the internal consis-
tencies for each scale by use of the GLB, internal consistency was
good (GLB¼0.91–0.96).
A ﬁnal psychometric test of the MASQ-D30 conducted in the
present study was a comparison to the CES-D, which has been
validated in younger populations (Radloff, 1991). Correlations were
only marginally lower than those between the CES-D and the
original MASQ. As expected, CES-D total scores were most highly
correlated with the GD subscale of the MASQ-D30. Correlations
between subscales of the two measures showed the expected
patterns: GD was also most strongly associated with the
‘depressed affect’ subscale of the CES-D, AD was most strongly
associated with the ‘lack of happiness’ subscale, and AA was most
strongly associated with ‘somatic & retardation’. Taken together,
the results indicated good convergent and divergent properties for
the MASQ-D30 scales.
For the current study we chose to primarily focus on the MASQ-
D30. However, for completeness, we also evaluated the psychometric
properties of the other two MASQ short forms, Mini-MASQ (Casillas
and Clark, 2000) and the ADDI-27 (Osman et al., 2011) (see
Supplementary data). We compared the items in each of the scales
and found that there was substantial overlap (for 40% to 61% of
items). With regard to the internal consistencies, similar results were
found for each of the short forms. Scale intercorrelations indicated
the most substantial differentiation between AD and AA on all scales
(ρ¼0.33–0.46), although this was stronger in the MASQ-D30 and
ADDI-27 than in the Mini-MASQ. Correlations with CES-D subscales
indicated similar convergent and divergent properties for each scale.
Overall, the three short-forms of the MASQ performed comparatively
to each other and to the original MASQ. Therefore, the choice of
which scale to use should be guided by a preference for certain item
coverage or the scale’s prior use in similar populations. In psychiatric
epidemiological research, the MASQ-D30 appears to have been the
most robustly tested and most often used.
In summary, this is the ﬁrst validation of the MASQ-D30 in an
adolescent and young adult sample. It is also the ﬁrst validation of
the short measure in English. The MASQ-D30 was found to be a
reliable and valid measure of affect and arousal in this young help-
seeking sample. There are limitations to the study. The sample was
relatively small, which was suboptimal for the factor analyses that
was conducted and may have affected the precision of results.
Also, all short form analyses were based on data collected with the
90-item original MASQ. As such, the current analyses can only be
seen as an evaluation of the usefulness and feasibility of a MASQ
short form in the current population. The results do suggest that
the MASQ-D30 can be used without compromising psychometric
quality. However, subsequent, work is needed with independent
(preferably larger) data collected with autonomous MASQ-D30
administrations, to gain a full psychometric validation of the
MASQ-30 as a standalone instrument.. Validation of the measure
should also be conducted in samples with varying severity of
symptoms and in samples with comorbid psychosis and/or bipolar
symptoms. Test-retest reliability could be investigated by the use
of two closely spaced administrations in the same sample.
In conclusion, the current work shows that it is possible to
reliably and validly measure the tripartite dimensions in adoles-
cent help-seekers by use of a short form measure.
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